A detailed history of Lazard Asset Management LLC transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Lazard Asset Management LLC holds 3,785 shares of FLGT stock, worth $65,139. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,785
Holding current value
$65,139
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$19.6 - $25.06 $74,186 - $94,852
3,785 New
3,785 $82,000
Q4 2022

Feb 14, 2023

BUY
$29.23 - $40.28 $45,481 - $62,675
1,556 New
1,556 $46,000
Q1 2022

May 13, 2022

SELL
$49.85 - $96.11 $212,560 - $409,813
-4,264 Reduced 83.18%
862 $53,000
Q4 2021

Feb 09, 2022

BUY
$77.3 - $105.0 $396,239 - $538,230
5,126 New
5,126 $515,000

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $521M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.